Took Too High a Dose of Wegovy: What Actually Happens and What to Do

The myth: a higher dose means faster results

This is probably the most persistent misunderstanding our prescribers hear most weeks, the idea that jumping ahead to a higher dose will simply speed up weight loss. It is understandable. If 1.7mg makes you feel less hungry, surely 2.4mg will work faster? In practice, the titration schedule for Wegovy is not a cautious formality. It exists because semaglutide slows gastric emptying and suppresses appetite through the GLP-1 pathway, and your gut needs time to adjust to each level before the next one is added. Take more than your body has adapted to, and the result is rarely accelerated weight loss. More often it is days of severe nausea, repeated vomiting, and diarrhoea severe enough to cause dehydration. Some people cannot keep fluids down. Far from helping, that pattern can stall progress and makes people more likely to stop treatment altogether. The full Wegovy dosing schedule is structured precisely to prevent this.

The clinical evidence for the 2.4mg maintenance dose (including the STEP 1 trial, published in the New England Journal of Medicine) was built on participants who followed that stepped approach. Shortcuts were not part of the protocol.

What taking too high a dose of Wegovy actually does to you

Semaglutide has an elimination half-life of approximately seven days. That means if you inject a dose your body was not ready for, the effects persist. You are not dealing with a medicine that clears in a few hours. Nausea and vomiting may dominate the first two to four days, then gradually ease as the week progresses, only to return when the next injection is due. If vomiting is frequent enough to prevent you keeping fluids down, dehydration becomes a real risk, and dehydration can strain your kidneys. People who are also on insulin or sulphonylureas for diabetes face an additional concern: semaglutide lowers blood glucose, and at unexpectedly high exposures the risk of hypoglycaemia rises. If you experience severe, persistent stomach pain that radiates towards your back, with or without vomiting, seek urgent medical assessment. The MHRA has highlighted acute pancreatitis as a known, though infrequent, serious side effect of GLP-1 medicines, and that warning applies here. You can find more on what high-dose semaglutide does in the body and how the risk profile shifts at higher exposures.

For a clear account of recognised signs that your Wegovy dose is too high, including which symptoms warrant a call to 111 versus a routine prescriber conversation, that page covers each one.

What to do right now if you think you took the wrong dose

First, stop and take stock. Did you take the wrong pen by mistake, take two injections in one week, or inject at the wrong point in your titration? Each situation carries different implications. If you accidentally took two doses in a short window, the guidance from the NHS semaglutide medicines page is clear: do not take an additional dose to compensate and do not skip the following week's scheduled injection. Your injection calendar simply resets from that point. If you have symptoms that worry you, contact 111 or your GP. For anything severe (fainting, chest pain, confusion, inability to keep any fluid down for more than a few hours) 999 or A&E is the right call.

If you are unsure whether what you experienced was a dose error or simply a normal side-effect peak after a planned increase, that is exactly the kind of question to raise before your next injection rather than after. There is a full walkthrough of what to do after taking the wrong Wegovy dose including the step-by-step checklist. For the broader context of how higher Wegovy doses are managed as part of a supervised programme, that page sits alongside this one.

Going forward: getting the dose right under clinical supervision

The goal after any dose confusion is to stabilise, not accelerate. If the too-high dose caused significant side effects, your prescriber may recommend staying at your current confirmed dose for longer before moving up. That is not a setback. It is the same logic that built the titration schedule in the first place: your body adjusting well at a given dose predicts far better long-term tolerance than pushing quickly to the top. Trying to work out the right path alone, particularly after a dose error, is where things tend to go wrong a second time.

If you are exploring what supervised weight-loss treatment looks like when the clinical review is built in from the start, the treatment options and free consultation page sets out how that works at nume. Every dose review is conducted by a GPhC-registered prescriber (a real clinician reads your answers) before any change is confirmed. No dose increase goes through without that check. And if you have broader questions about how Wegovy fits into the wider picture of medical weight management, the weight-loss treatment overview covers the landscape plainly.